Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: A pilot study

Prenatal Diagnosis

Volumn 26, Issue 8, 2006, Pages 719-724

  Giordano, P C ^a   Plancke, A ^a   Van Meir, C A ^b   Janssen, C A H ^b   Kok, P J M J ^b   Van Rooijen Nijdam, I H ^b   Tanis, B C ^b   Van Huisseling, J C M ^b   Versteegh, F G A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GROENE HART HOSPITAL   (Netherlands)

Author keywords

Hemoglobinopathies; Pregnancy; Prevention

Indexed keywords

FERRITIN; IRON;

ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEASIBILITY STUDY; FEMALE; HEMOGLOBINOPATHY; HETEROZYGOTE DETECTION; HOSPITAL; HUMAN; IMMIGRANT; IRON DEFICIENCY; MICROCYTIC ANEMIA; NETHERLANDS; OUTPATIENT CARE; PHENOTYPE; PILOT STUDY; PREGNANT WOMAN; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING;

ADULT; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; FEMALE; GENETIC SCREENING; GENETIC TESTING; HEMOGLOBINOPATHIES; HETEROZYGOTE; HUMANS; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE;

EID: 33747432941     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1490     Document Type: Article

References (21)

1. Bernini LF, Harteveld CL. 1998. Harteveld CL Alpha-thalassaemia. Baillieres Clin Haematol 11(1): 53-90.
2. Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. 2000. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assess 4(3): i-v, 1-99.
3. Da Silva EM, Absence of sickling phenomenon of the red blood corpuscle among Brazilian Indians. Science, 1948. 107: 221-222.
4. De Jonge A. 2005. KNOV-standpunt prenatale diagnostiek. KNOW publication, info@knov.nl.
5. Elion-Gerritzen WE, Giordano PC, Haak HL. 2002. Anemia in the midwife practice. Standard issued by the Royal Dutch Organisation of Midwives: a risk of not recognizing iron deficiency and hemoglobinopathy. Ned Tijdschr Geneeskd 146(10): 457-459.
6. Galanello R, Eleftheriou A, Traeger Synodinos J, Old J, Petrou M, Angastiniotis M. 2003. Prevention of Thalassemia and Other Hemoglobin Disorders, vol 1. Thalassemia Int. Federation: ISBN 9963-623-39-5.
7. Gill C. 2004. Review of hemoglobinopathy screening in the South East England Region. Commissioned on behalf of the NHS Sickle Cell & Thalassaemia Screening Programme By the South East England Government Office, http://www.kcl-phs.org.uk/haemscreening.
8. Giordano PC, Breuning MH. 2000. Van gen naar ziekte; van hemoglobinegenen naar thalassemie en sikkelcelanemie. Ned Tijdschr Geneeskd 144: 1910-1913.
9. Giordano PC, Bouva MJ, Harteveld CL. 2004. A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for prevention strategy in the Netherlands. Hemoglobin 28(4): 287-296.
10. Giordano PC, Dihal AA, Harteveldt CL. 2005. Estimating the attitude of immigrants toward primary prevention of the hemoglobinopathies. Prenal Diagn 25: 885-893.
11. Giordano PC, Harteveld CL, Heister JGAM, et al. 1998. The molecular spectrum of beta-Thalassemia and Abnormal hemoglobins in the allochthonous and autochthonous dutch population. Community Genet 1: 243-251.
12. Harteveld CL, Thelen MH, Rutten JJ, et al. 2005a. Hb Geldrop St. Anna beta94(FG1)Asp → Tyr]: a new hemoglobin variant observed in a diabetic patient. Hemoglobin 29(2): 107-112.
13. Harteveld CL, Voskamp A, Phylipsen M, et al. 2005b. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet 42(12): 922-931.
14. Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. 2000. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol 108(2): 295-299.
15. Losekoot M, Fodde R, Harteveld CL, Van Heeren H, Giordano PC, Bernini LF. 1990. Denaturing gradient gel electrophoresis and direct sequencing of amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassemia. Br J Haematol 176: 269-276.
16. Qureshi N, Armstrong S, Modell B. 2006. GPs' opinions of their role in prenatal genetic services: a cross-sectional survey. Fam Pract 23(1): 106-110.
17. Samavat A, Modell B. 2004. Iranian national thalassaemia screening programme. BMJ 329(7475): 1134-1137.
18. Schulpen TW, Van der Lee JH, Van Der Most Van Spijk MW, Beemer FA. 1998. Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune. Ned Tijdschr Geneeskd 142(18): 1019-1022.
19. Steinberg MH, Forget BG, Higgs DR, Nagel RL. 2001. Disorders of Hemoglobin. Cambridge University Press.
20. Weatherall DJ, Clegg JB. 2001. Inherited hemoglobin disorders: an increasing global health problem. Bull World Health Organ 79(8): 704-712.
21. Yavarian M, Karimi M, Zorai A, Harteveld CL, Giordano PC. 2005. Molecular basis of Hb H disease in southwest Iran. Hemoglobin 29(1): 43-50.